Clearside Biomedical, Inc. (CLSDQ) vs Propanc Biopharma Inc (PPCB)

Clearside Biomedical, Inc. and Propanc Biopharma Inc are both Biotechnology companies. Clearside Biomedical, Inc. and Propanc Biopharma Inc are of similar size ($2.2M and $2.1M). Clearside Biomedical, Inc. has negative trailing earnings, so its P/E is not meaningful; Propanc Biopharma Inc trades at 0.0×. Propanc Biopharma Inc has the higher net margin (0.00% vs −780.9%) and the lower return on invested capital (−116.6% vs 0.00%). Across the 12 metrics below, Propanc Biopharma Inc leads on 8 and Clearside Biomedical, Inc. on 4.

Valuation

Metric CLSDQ PPCB Biotechnology median
P/E n/m 0.00 7.88
P/S 0.39 n/m 11.47
P/B n/m 0.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 10.91 n/m 10.73
Earnings yield (2,075.24%) 257,474.29% (28.84%)
Free cash flow yield (1,661.90%) (739.21%) (23.03%)

Profitability

Metric CLSDQ PPCB Biotechnology median
Gross margin 92.55% — 65.16%
Operating margin (689.76%) 0.00% 0.00%
Net margin (780.93%) 0.00% 0.00%
Free cash flow margin (653.23%) 0.00% 0.00%
Return on equity 58.59% (138.20%) (57.72%)
Return on assets (127.43%) (104.68%) (49.22%)
Return on invested capital 0.00% (116.59%) 0.00%

Growth

Metric CLSDQ PPCB Biotechnology median
Revenue growth (TTM) (56.78%) — 5.64%
EPS growth (last fiscal year) 11.32% 98.81% —
Revenue growth, 5-year CAGR (5.20%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLSDQ PPCB Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 2.98 2.37 4.73
Net debt to EBITDA 0.69 (0.01) 0.96

Dividend

Metric CLSDQ PPCB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric CLSDQ PPCB Biotechnology median
Market cap 2.15m 2.14m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack